Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Green Growth Brands Significant Revenue Growth Driven by CBD Retail Expansion

      Green Growth Brands (CNW Group/Green Growth Brands)

      News provided by

      Green Growth Brands

      Nov 25, 2019, 17:00 ET

      Share this article

      Share this article


      Total first quarter fiscal 2020 revenues increased 77% quarter-over-quarter to $12.7 million

      Well-positioned for upcoming holiday season with network of 193 CBD shops

      COLUMBUS, OH, Nov. 25, 2019 /PRNewswire/ - Green Growth Brands Inc. (GGB or the Company) (CSE: GGB) (OTCQB: GGBXF) today reported its results for the thirteen-week period ended September 28, 2019. Revenues for the period totaled $12.7M.

      "As we approach the holiday shopping season, we are confident in our growth trajectory," said Peter Horvath, CEO of Green Growth Brands. "We are proud of the topline growth we accomplished in Q1 and are extremely pleased with our current results, which are an indication of future growth. In fact, the four weeks of fiscal November, retail CBD sales were two-thirds of our total CBD sales reported in all of the thirteen weeks of first quarter fiscal 2020, which we are reporting today. This topline growth is reflective of our shift from investing in the foundation of our CBD business to focusing on its execution.

      "In a very short-time we have grown a meaningful CBD footprint. We believe our products, network of shops, rapidly growing web business and wholesale relationships position us as a leader in the industry. In the coming quarters we look-forward to reporting similar trends and results for our MSO segment of the business. As we begin to reach scale our consumer and operations expertise will be clearly reflected, not only in the customer experiences we create and the loyalty we drive, but also in our financials as we work towards profitability."

      View Seventh Sense's holiday campaign and holiday gifting assortment here.  

      GGB will host a conference call and audio webcast with Chief Executive Officer, Peter Horvath, Chief Operating Officer, Randy Whitaker, and Chief Financial Officer, Brian Logan, at 8:30 AM EST on Tuesday, November 26, 2019.

      First Quarter Fiscal 2020 Highlights

      • Total revenue for the period was $12.7 million, a sequential increase of 77% over the prior quarter.

      • Pro forma revenues for the quarter were $15.3 million, reflecting a full quarter of revenue from The+Source Henderson, which was acquired on August 28, 2019.

      • MSO revenues for the quarter were $7.6M, a sequential increase of 38% over the prior quarter, primarily driven by the acquisition of The+Source Henderson.

      • The two Nevada-based The+Source dispensaries continue to generate annualized revenue of nearly $15,000 per selling square foot. A best-in-class figure in the cannabis industry and in retail overall.

      • CBD revenue for the quarter was $5.1 million, a sequential increase of 201% over the prior quarter. Growth was primarily driven by additional mall-based shop openings, growth in wholesale, and increased overall brand awareness. The Company expects to achieve over $10 million in CBD revenues in second quarter fiscal 2020.

      • The Company opened 81 mall-based CBD shops during the quarter, bringing the total number of shops open at quarter's end to 139 in 34 states. The Company currently operates 193 shops.

      • The Company began filling American Eagle Outfitter's white label order for 'Mood' during the quarter. Performance indications are strong, and the Company expects to continue partnering with American Eagle.

      __________________________

      1 eMarketer Retail, "Ecommerce trends and store sales for top retailers"

      First Quarter Fiscal 2020 Financial Statements

      The following tables contain financial information for the periods indicated. For full financial information, notes, and management commentary please refer to the MD&A and Financial Statements posted on Green Growth Brands' Investor Relations site and SEDAR. All financial information is provided in United States dollars, unless otherwise indicated. "Adjusted EBITDA" is equal to net income (loss) before interest, taxes and depreciation and amortization, plus fair value adjustments on sale of inventory and on growth of biological assets, share-based compensation and payments, loss (gain) on equity investments, loss (gain) on foreign exchange, loss (gain) on short-term investments, transaction costs, listing fees and certain one-time non-operating expenses, as determined by management. Management believes this measure provides useful information as it is a commonly used measure in the capital markets and as it is a close proxy for repeatable cash generated by (used for) operations.

      Unaudited Condensed Interim Consolidated Statements of Financial Position

      As at September 28, 2019 and June 30, 2019

      (Expressed in United States dollars)





      September 28, 2019

      June 30, 2019





      Assets



      Current Assets




      Cash and cash equivalents

      $

      6,811,539

      $

      10,256,008


      Receivables

      2,240,238

      580,529


      Prepaid expenses

      3,452,367

      5,142,618


      Inventories

      11,282,915

      10,244,804


      Biological assets

      1,321,379

      1,352,097


      Notes receivable

      48,103

      47,739


      Other receivables

      2,969,527

      3,006,760


      Deferred lease charges

      -

      727,518



      28,126,068

      31,358,073

      Non-current assets




      Deposits and other assets

      604,414

      2,880,186


      Deferred lease charges

      -

      2,606,940


      Notes receivable

      166,724

      17,999,224


      Property and equipment, net

      29,052,104

      18,761,723


      Right-of-use assets

      69,114,716

      -


      Intangible assets

      101,991,179

      39,925,984


      Goodwill

      58,398,385

      36,253,417

       Total assets

      $

      287,453,590

      $

      149,785,547





      Liabilities



      Current Liabilities




      Accounts payable and accrued liabilities

      27,370,962

      16,028,807


      Taxes payable

      514,535

      282,593


      Due to related parties

      8,464,855

      317,535


      Notes payable

      34,878,986

      45,762,540


      Lease liabilities

      10,512,065

      -


      Embedded derivative liabilities

      618,774

      1,496,214


      Convertible debentures

      46,922,616

      41,623,041



      129,282,793

      105,510,730

      Non-current liabilities




      Long term accrued liabilities

      1,205,010

      299,977


      Lease liabilities

      57,012,239

      -


      Embedded derivative liabilities

      1,188,467

      -


      Convertible debentures

      8,758,271

      -


      Deferred tax liability

      6,985,048

      1,437,324



      75,149,035

      1,737,301

      Shareholders' Equity




      Share capital

      182,371,023

      119,881,374


      Reserve for warrants

      16,538,786

      9,054,624


      Reserve for share-based compensation

      3,813,158

      3,147,110


      Accumulated deficit

      (122,566,395)

      (92,453,943)


      Accumulated other comprehensive income

      148,286

      148,286

      Total equity attributable to shareholders of Green Growth Brands Inc

      80,304,858

      39,777,451

      Non-controlling interest

      2,716,904

      2,760,065

      Total equity

      83,021,762

      42,537,516

       Total liabilities and equity

      $

      287,453,590

      $

      149,785,547

      Adjusted EBITDA



      (Expressed in United States dollars)





      September 28,

      September 30,



      2019

      2018






      Net loss after listing fees before income taxes

      $ (29,886,676)

      $   (2,846,537)






      Fair value adjustment on sale of inventory

      906,919

      -


      Fair value adjustment on biological assets

      (507,284)

      -


      Stock based compensation

      1,632,922

      -


      Depreciation and amortization

      3,626,529

      -


      Pre-opening expenses

      1,547,468

      -


      Non-operating expenses

      6,264,165

      156,102


      Termination and severance

      421,396

      -


      Writedown of developed technology

      573,662

      -


      Other non-operating expenses

      197,204

      -



      14,662,981

      156,102


      Adjusted EBITDA

      $ (15,223,695)

      $   (2,690,435)

      Unaudited Condenseed Interim Consolidated Statements of Loss

      For the 13 weeks ended September 28 2019 and for the three months ended September 30, 2018




      (Expressed in United States dollars)







      September 28,
      2019

      September 30,
      2018




      Sales



      Revenue

      $

      12,701,958

      $

      -

      Cost of goods sold

      10,911,000

      -

      Gross profit before fair value adjustments

      1,790,958

      -

      Fair value change in biological assets
      included in inventory sold and other charges

      906,919

      -

      Unrealized gain on changes in fair value of
      biological assets

      (507,284)

      -

      Gross profit

      1,391,323

      -




      Operating Expenses



      General and administrative

      9,683,667

      2,450,960

      Sales and marketing

      10,070,716

      -

      Share-based compensation

      1,632,922

      -

      Depreciation and amortization

      3,626,529

      -


      25,013,834

      2,450,960


      (23,622,511)

      (2,450,960)

      Other expenses (income)



      Gain in fair value of derivative liabilities

      (4,240,710)

      -

      Interest expense, net

      3,761,477

      217

      Accretion on convertible debentures

      1,409,583

      -

      Foreign exchange (gain) loss

      (488,387)

      155,885

      Transaction costs

      5,822,202

      -

      Net loss before listing fees and income taxes

      (29,886,676)

      (2,607,062)

      Listing fees

      -

      239,475

      Net loss after listing fees

      (29,886,676)

      (2,846,537)

       Income taxes

      356,609

      -

      Net loss after income taxes

      $

      (30,243,285)

      $

      (2,846,537)

      Less:Non-controlling interest

      43,161

      -

      Net Loss attributable to owners of the parent

      $

      (30,200,124)

      $

      (2,846,537)




      Net loss per Common Share attributable to the parent



      Basic and Diluted

      $

      (0.15)

      $

      (0.03)




      Weighted average common shares

      198,246,478

      84,428,676

      Unaudited Condensed Interim Consolidated Statement of Cashflow

      For the 13 weeks ended September 28, 2019, and for the three months ended September 30, 2018

      (Expressed in United States dollars)





      September 28,
      2019

      September 30,
      2018

      Cashflow from Operating Activities




      Net loss after income taxes for the period

      $

      (30,243,285)

      $

      (2,846,537)

      Adjustments for:




      Stock based compensation

      1,632,922

      -


      Shares and warrants issued for services and fees

      4,115,733

      567,884


      Depreciation and amortization

      3,578,965

      -


      Writedown of developed software

      409,022

      -


      Deferred tax expense

      (225,333)

      -


      Accretion expense

      1,409,583

      -


      Gain in fair value of embedded derivative liabilities

      (4,240,710)

      -


      Net fair value adjustment on biological assets

      399,635

      -


      Foreign exchange on translation

      (488,387)

      -

      Changes in working capital balances




      Receivables

      (1,646,660)

      -


      Prepaid expenses

      1,690,251

      -


      Other receivables

      1,994,059

      (185,874)


      Inventories

      (27,538)

      -


      Biological assets

      (368,917)

      -


      Accounts payable and accrued liabilities

      8,815,006

      (787,634)


      Taxes payable

      231,942

      -



      (12,963,712)

      (3,252,161)

      Cashflow from Investing Activities




      Purchase of property and equipment

      (9,723,474)

      -


      Purchase of software

      (723,738)

      -


      Acquisition of business and assets, net of cash acquired

      (12,703,263)

      -


      Proceeds from sale of equity investment

      11,792

      -


      Advances on acquisitions

      -

      (32,347,500)



      (23,138,683)

      (32,347,500)

      Cashflow from Financing Activities




      Cash received on warrants exercised

      298,420

      -


      Proceeds from bought deal financing

      36,513,665

      -


      Repayment of notes

      (15,485,000)

      -


      Principal payments of lease liabilities

      (1,589,689)

      -


      Proceeds from promissory notes

      12,794,844

      -


      Proceeds from convertible debentures, net of issuance costs

      -

      66,061,829



      32,532,240

      66,061,829

      Effect of exchange rates on cash

      125,686

      -

      Increase in cash

      (3,444,469)

      30,462,168





      Cash, beginning of period

      10,256,008

      4,688,311





      Cash, end of period

      $

      6,811,539

      $

      35,150,479





      Supplemental disclosure of cash flow information




      Interest paid

      445,232

      -


      Income taxes paid

      350,000

      -

      Other non-cash investing and financing activities




      Change in accrual for construction in progress

      861,479

      -


      Acquisition of business for non-cash

      47,107,913

      -


      Issuance of shares for underwriter fees on bought deal financing

      2,080,494

      -

      Segmented statement of operations for the 14 weeks ended September 28, 2019 and three months ended September 30, 2018


      (Expressed in United States dollars)



      MSO

      CBD

      Head office

      Allocations

      Total



      2019

      2018

      2019

      2018

      2019

      2018

      2019

      2018

      2019

      2018













      Sales












      Revenue

      $

      7,555,102

      $

      -

      $

      5,146,856

      $

      -

      $

      -

      $

      -

      $

      -

      $

      -

      $

      12,701,958

      $

      -


      Cost of goods sold

      4,575,274

      -

      4,576,384

      -

      -

      -

      1,759,342

      -

      10,911,000

      -

      Gross profit before fair value adjustments

      2,979,828

      -

      570,472

      -

      -

      -

      (1,759,342)

      -

      1,790,958

      -


      Fair value change in biological assets included in
      inventory sold and other charges

      906,919

      -

      -

      -

      -

      -

      -

      -

      906,919

      -


      Unrealized gain on changes in fair value of biological
      assets

      (507,284)

      -

      -

      -

      -

      -

      -

      -

      (507,284)

      -

      Gross profit

      2,580,193

      -

      570,472

      -

      -

      -

      (1,759,342)

      -

      1,391,323

      -













      Operating Expenses












      General and administration

      -

      -

      -

      -

      11,433,502

      2,450,960

      (1,749,835)

      -

      9,683,667

      2,450,960


      Sales and marketing

      1,710,707

      -

      8,360,009

      -

      -

      -

      -

      -

      10,070,716

      -


      Stock based compensation

      -

      -

      -

      -

      1,632,922

      -

      -

      -

      1,632,922

      -


      Depreciation and amortization

      142,564

      -

      2,865,550

      -

      627,922

      -

      (9,507)

      -

      3,626,529

      -



      1,853,271

      -

      11,225,559

      -

      13,694,346

      2,450,960

      (1,759,342)

      -

      25,013,834

      2,450,960



      726,922

      -

      (10,655,087)

      -

      (13,694,346)

      (2,450,960)

      -

      -

      (23,622,511)

      (2,450,960)

      Non-operating expenses












      Gain in fair value of derivative liabilities

      -

      -

      -

      -

      (4,240,710)

      -

      -

      -

      (4,240,710)

      -


      Interest expense, net

      21,712

      -

      1,117,964

      -

      2,621,801

      217

      -

      -

      3,761,477

      217


      Accretion expense

      -

      -

      -

      -

      1,409,583

      -

      -

      -

      1,409,583

      -


      Foreign exchange (gain) loss

      -

      -

      -

      -

      (488,387)

      155,885

      -

      -

      (488,387)

      155,885


      Transaction costs

      -

      -

      -

      -

      5,822,202

      -

      -

      -

      5,822,202

      -

      Net income (loss) before listing fees and income taxes

      705,210

      -

      (11,773,051)

      -

      (18,818,835)

      (2,607,062)

      -

      -

      (29,886,676)

      (2,607,062)


      Listing fees

      -

      -

      -

      -

      -

      239,475

      -

      -

      -

      239,475

      Net income (loss) after listing fees

      705,210

      -

      (11,773,051)

      -

      (18,818,835)

      (2,846,537)

      -

      -

      (29,886,676)

      (2,846,537)


       Income taxes

      356,609

      -

      -

      -

      -

      -

      -

      -

      356,609

      -

      Net income (loss) after income taxes

      $

      348,601

      $

      -

      $

      (11,773,051)

      $

      -

      $

      (18,818,835)

      $

      (2,846,537)

      $

      -

      $

      -

      $

      (30,243,285)

      $

      (2,846,537)













      Net income (loss) and comprehensive loss attributable to:












      Owners of the parent

      391,762

      -

      (11,773,051)

      -

      (18,818,835)

      (2,846,537)

      -

      -

      (30,200,124)

      (2,846,537)


      Non-controlling interest

      43,161

      -

      -

      -

      -

      -

      -

      -

      43,161

      -



      348,601

      -

      (11,773,051)

      -

      (18,818,835)

      (2,846,537)

      -

      -

      (30,243,285)

      (2,846,537)













      Supplemental segemented information












      Assets

      173,818,672

      -

      101,694,365

      -

      11,940,553

      67,702,122

      -

      -

      287,453,590

      67,702,122


      Liabilities

      32,201,594

      -

      79,177,273

      -

      93,052,961

      66,925,655

      -

      -

      204,431,828

      66,925,655

      Conference Call Information:

      Conference ID: 54236169

      Local Toronto Dial-in Number: (+1) 416 764 8609

      Local Vancouver Dial-in Number: (+1) 778 383 7417

      North American Toll-Free Number: (+1) 888 390 0605

      The call and replay archive will be accessible on Green Growth Brands' Investor Relations website.

      About Green Growth Brands Inc.
      Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company's brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and 8 Fold. The Company also has a licensing agreement with the Greg Norman™ Brand to develop a line of CBD-infused personal care products designed for active wellness. GGB is expanding its cannabis operations throughout the U.S., via dispensaries in Nevada, Massachusetts and Florida and the largest network of CBD shops in malls across the country and ShopSeventhSense.com. Learn more about the vision at  GreenGrowthBrands.com.

      Cautionary Statements:

      Certain information in this news release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "intend", "forecast" and similar expressions.   Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical and recreational marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the marijuana industry in the United States, income tax and regulatory matters; the ability of the Company to implement its business strategies; competition; currency and interest rate fluctuations and other risks, including those factors described under the heading "Risks Factors" in the Company's Annual Information Form dated November 26, 2018 which is available on the Company's issuer profile on SEDAR.

      Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements contained in this release, including, but not limited to, the Company's ability to execute on its growth strategy, the Company's plan to open new dispensaries in the remainder of the calendar year, the Company's vision to become a multi-state operator with retail stores exceeding certain financial thresholds is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

      This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any securities and neither this announcement nor anything contained in it shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or in any other jurisdiction in which such an offer would be illegal.

      The securities referred to herein have not been and will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, within the United States, unless the securities have been registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

      SOURCE Green Growth Brands

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.